Has Michael Beninato, PA received payments from drug or device companies?

Yes. Drug and device makers reported $2,186 in general payments to Michael Beninato, PA across 74 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Beninato, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Beninato, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Beninato, PA

Surgical · Slidell, LANPI 1043286388

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $699, 4.3 times the $165 reported in 2021.

$2,186in general payments, 2019–2025

Across 74 payments — averaging $29.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$391
Biotronik NRO, Inc.$267
Stryker$183
Edwards Lifesciences$172
Alnylam Pharmaceuticals Inc.$172
Amgen$154
plus $848 from 12 others

What the payments were for

Food & beverage$2,186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	30	$391
Biotronik NRO, Inc.	7	$267
Stryker	6	$183
Edwards Lifesciences	1	$172
Alnylam Pharmaceuticals Inc.	5	$172
Amgen	7	$154
Abbott	2	$146
Novo Nordisk	1	$122
Actelion Pharmaceuticals US, Inc.	1	$122
Gilead	1	$113
Jazz Pharmaceuticals Inc.	1	$85
Saluda Medical Americas, Inc.	4	$74
Boston Scientific	2	$50
Virtus Pharmaceuticals LLC	2	$47
Bioventus LLC	1	$36
Convatec Inc.	1	$21
Nevro Corp.	1	$19
Valinor Pharma, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$172
ETERNA$135
Ozempic$122
UPTRAVI$122
OPSUMIT$122
PENNSAID$116
Epclusa$113
GIVLAARI$103
Prospera$101

How this compares

$2,186 in reported general payments places this provider in the 80th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana →

Medicare billing

Part B allowed, 2024

$35,389

Medicare patients

124

Services billed

1,779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	88	$773
Tizanidine Hcl	70	$668
Pregabalin	22	$614
Cyclobenzaprine Hcl	63	$415
Ibuprofen	28	$326
Methocarbamol	34	$263
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	33	$196
Baclofen	27	$195
Meloxicam	68	$126
Ketorolac Tromethamine	11	$101
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	12	$82
Tramadol Hcl	35	$66
Trazodone Hcl	11	$34

Paid to pharmacies, not to this prescriber.